Variant report

Variant	nsv897322
Chromosome Location	chr11:46739748-46748916
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:267)
CpG islands
(count:793)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:267 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:46739747-46740958	HepG2	liver:	n/a	n/a
2	BCL3	chr11:46739616-46740815	A549	lung:	n/a	chr11:46740140-46740149
3	BRCA1	chr11:46739790-46739955	HepG2	liver:	n/a	n/a
4	BRCA1	chr11:46741180-46741221	HepG2	liver:	n/a	n/a
5	BRCA1	chr11:46740619-46740828	HepG2	liver:	n/a	n/a
6	CBX3	chr11:46744282-46744716	K562	blood:	n/a	n/a
7	CBX3	chr11:46744326-46744574	K562	blood:	n/a	n/a
8	CBX3	chr11:46747731-46748037	K562	blood:	n/a	n/a
9	CEBPB	chr11:46740603-46740837	A549	lung:	n/a	n/a
10	CEBPB	chr11:46739747-46740051	HepG2	liver:	n/a	n/a
11	CEBPB	chr11:46740455-46740974	HepG2	liver:	n/a	n/a
12	CEBPB	chr11:46740522-46740956	HepG2	liver:	n/a	n/a
13	CEBPB	chr11:46740524-46740932	HepG2	liver:	n/a	n/a
14	CEBPB	chr11:46740566-46740820	HepG2	liver:	n/a	n/a
15	CEBPB	chr11:46744828-46744995	HepG2	liver:	n/a	chr11:46744909-46744920
16	CEBPD	chr11:46739660-46740239	HepG2	liver:	n/a	n/a
17	CEBPD	chr11:46740419-46740796	HepG2	liver:	n/a	n/a
18	CEBPD	chr11:46740489-46741094	HepG2	liver:	n/a	n/a
19	CEBPZ	chr11:46740300-46740420	HepG2	liver:	n/a	n/a
20	CHD2	chr11:46739731-46740126	HepG2	liver:	n/a	n/a
21	CHD2	chr11:46740517-46740886	HepG2	liver:	n/a	n/a
22	CREB1	chr11:46739562-46740150	A549	lung:	n/a	n/a
23	CTCF	chr11:46740680-46740830	HepG2	liver:	n/a	n/a
24	CTCF	chr11:46747540-46747690	HEK293	kidney:	n/a	n/a
25	CTCF	chr11:46740860-46741010	HepG2	liver:	n/a	n/a
26	CTCF	chr11:46747560-46747710	HepG2	liver:	n/a	n/a
27	CTCF	chr11:46739980-46740130	HepG2	liver:	n/a	n/a
28	CTCF	chr11:46740620-46740770	HepG2	liver:	n/a	n/a
29	CTCF	chr11:46747700-46747850	Hela-S3	cervix:	n/a	n/a
30	CTCF	chr11:46747660-46747810	HBMEC	blood vessel:	n/a	n/a
31	CTCF	chr11:46744460-46744610	HepG2	liver:	n/a	n/a
32	EBF1	chr11:46745767-46745815	GM12878	blood:	n/a	n/a
33	ELF1	chr11:46739670-46740165	MCF-7	breast:	n/a	chr11:46739889-46739902
34	ELF1	chr11:46739619-46740278	HepG2	liver:	n/a	chr11:46739889-46739902
35	ELF1	chr11:46739702-46740259	HepG2	liver:	n/a	chr11:46739889-46739902
36	ELF1	chr11:46739695-46740102	K562	blood:	n/a	chr11:46739889-46739902
37	ELF1	chr11:46739672-46740102	A549	lung:	n/a	chr11:46739889-46739902
38	ELF1	chr11:46739716-46740096	A549	lung:	n/a	chr11:46739889-46739902
39	EP300	chr11:46739581-46740215	A549	lung:	n/a	chr11:46739739-46739752 chr11:46739892-46739901 chr11:46740042-46740058
40	EP300	chr11:46740335-46740969	HepG2	liver:	n/a	chr11:46740866-46740879
41	EP300	chr11:46739589-46740250	HepG2	liver:	n/a	chr11:46739739-46739752 chr11:46739892-46739901 chr11:46740042-46740058
42	EP300	chr11:46740525-46740872	HepG2	liver:	n/a	n/a
43	EP300	chr11:46739704-46740266	HepG2	liver:	n/a	chr11:46739739-46739752 chr11:46739892-46739901 chr11:46740042-46740058
44	EP300	chr11:46739534-46740309	HepG2	liver:	n/a	chr11:46739739-46739752 chr11:46739892-46739901 chr11:46740042-46740058
45	EP300	chr11:46740427-46740979	HepG2	liver:	n/a	chr11:46740866-46740879
46	EP300	chr11:46739564-46740360	A549	lung:	n/a	chr11:46739739-46739752 chr11:46739892-46739901 chr11:46740042-46740058
47	ETS1	chr11:46739615-46740187	A549	lung:	n/a	chr11:46739893-46739907
48	FOSL2	chr11:46739628-46739999	A549	lung:	n/a	n/a
49	FOSL2	chr11:46739680-46740268	HepG2	liver:	n/a	n/a
50	FOSL2	chr11:46740506-46740988	HepG2	liver:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:46740703-46740753	SAEC	small airway:	n/a
2	chr11:46748212-46748262	H1-hESC	embryonic stem cell:	embryo
3	chr11:46740666-46740716	PANC-1	pancreas:	n/a
4	chr11:46741405-46741455	HL-60	blood:	n/a
5	chr11:46740790-46740840	HCPEpiC	choroid plexus:	n/a
6	chr11:46741373-46741423	GM12892	blood:	n/a
7	chr11:46741373-46741423	K562	blood:	n/a
8	chr11:46744754-46744804	Hela-S3	cervix:	n/a
9	chr11:46739832-46739882	Hepatocyte	liver:	n/a
10	chr11:46740032-46740082	HAEpiC	amniotic membrane:	n/a
11	chr11:46748294-46748344	U87	brain:	n/a
12	chr11:46740703-46740753	RPTEC	kidney:	n/a
13	chr11:46740790-46740840	ovcar-3	ovarian:	n/a
14	chr11:46741373-46741423	HAEpiC	amniotic membrane:	n/a
15	chr11:46740666-46740716	SK-N-MC	brain:	n/a
16	chr11:46744754-46744804	GM06990	blood:	n/a
17	chr11:46748294-46748344	NHDF-neo	bronchial:	n/a
18	chr11:46740481-46740531	HepG2	liver:	n/a
19	chr11:46741405-46741455	HRPEpiC	eye:	n/a
20	chr11:46739832-46739882	HIPEpiC	eye:	n/a
21	chr11:46746236-46746286	HPAEpiC	pulmonary alveolar:	n/a
22	chr11:46740790-46740840	U87	brain:	n/a
23	chr11:46740666-46740716	AoSMC	blood vessel:	n/a
24	chr11:46740481-46740531	AG09319	gingival:	n/a
25	chr11:46744754-46744804	Hepatocyte	liver:	n/a
26	chr11:46740481-46740531	PrEC	prostate:	n/a
27	chr11:46748294-46748344	HAEpiC	amniotic membrane:	n/a
28	chr11:46741299-46741349	NH-A	brain:	n/a
29	chr11:46740481-46740531	HEK293	kidney:	embryo
30	chr11:46746236-46746286	GM19239	blood:	n/a
31	chr11:46748294-46748344	K562	blood:	n/a
32	chr11:46740032-46740082	HPAEpiC	pulmonary alveolar:	n/a
33	chr11:46739832-46739882	NT2-D1	testis:	n/a
34	chr11:46740032-46740082	SK-N-MC	brain:	n/a
35	chr11:46739832-46739882	BE2_C	brain:	n/a
36	chr11:46740703-46740753	GM19239	blood:	n/a
37	chr11:46741405-46741455	MCF-7	breast:	n/a
38	chr11:46744754-46744804	GM19239	blood:	n/a
39	chr11:46740481-46740531	ProgFib	skin:	n/a
40	chr11:46741405-46741455	SKMC	muscle:	n/a
41	chr11:46740032-46740082	GM12878	blood:	n/a
42	chr11:46744754-46744804	PANC-1	pancreas:	n/a
43	chr11:46741405-46741455	SK-N-SH_RA	brain:	n/a
44	chr11:46740790-46740840	PrEC	prostate:	n/a
45	chr11:46741373-46741423	HPAEpiC	pulmonary alveolar:	n/a
46	chr11:46744754-46744804	K562	blood:	n/a
47	chr11:46748212-46748262	AG04449	skin:	fetal
48	chr11:46740790-46740840	GM12878	blood:	n/a
49	chr11:46740703-46740753	HRPEpiC	eye:	n/a
50	chr11:46748212-46748262	AG10803	skin:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:46723694..46726091-chr11:46747520..46750064,2	K562	blood:
2	chr11:46721125..46723767-chr11:46740816..46743369,3	K562	blood:
3	chr11:46738555..46741511-chr11:46744742..46747329,2	K562	blood:
4	chr11:46742083..46744335-chr11:46763243..46766196,2	K562	blood:
5	chr11:46722213..46727380-chr11:46743173..46747634,5	MCF-7	breast:
6	chr11:46747479..46750421-chr11:46771928..46774649,2	MCF-7	breast:
7	chr11:46746847..46748369-chr17:41380576..41383669,4	K562	blood:
8	chr11:46746847..46748367-chr17:41398813..41400492,2	K562	blood:
9	chr11:46746849..46748369-chr17:41382011..41383900,4	K562	blood:
10	chr11:46402912..46405362-chr11:46740261..46742073,2	K562	blood:
11	chr11:46741871..46743470-chr11:46744640..46747616,2	K562	blood:

No data

Variant related genes	Relation type
F2	TF binding region
F2	CpG island
ENSG00000110492	chromatin interactions
ENSG00000175220	chromatin interactions
ENSG00000236383	chromatin interactions
ENSG00000175216	chromatin interactions
ENSG00000175213	chromatin interactions
ENSG00000180210	chromatin interactions

Extended variants
information (count: 395 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:395 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3136430	chr11:46739748-46739749	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs187902605	chr11:46739810-46739811	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs192383078	chr11:46739814-46739815	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs531373693	chr11:46739868-46739869	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs184689330	chr11:46739923-46739924	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs561829730	chr11:46739935-46739936	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs527728420	chr11:46739954-46739955	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs547761417	chr11:46739971-46739972	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs570716910	chr11:46740116-46740117	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs146191573	chr11:46740130-46740131	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs4752930	chr11:46740164-46740165	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs550182019	chr11:46740168-46740169	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs570282407	chr11:46740180-46740181	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs536044837	chr11:46740244-46740245	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548334352	chr11:46740292-46740293	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs139078886	chr11:46740374-46740375	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs190230723	chr11:46740391-46740392	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs553735626	chr11:46740438-46740439	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs200285313	chr11:46740453-46740454	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs576714456	chr11:46740465-46740466	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs539741396	chr11:46740470-46740471	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs534993445	chr11:46740481-46740482	Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs181387146	chr11:46740533-46740534	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs575866593	chr11:46740595-46740596	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs541600790	chr11:46740596-46740597	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs550304022	chr11:46740644-46740645	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs561889205	chr11:46740675-46740676	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs144066258	chr11:46740704-46740705	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs541119948	chr11:46740707-46740708	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs564528021	chr11:46740731-46740732	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs367740275	chr11:46740736-46740737	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs184828110	chr11:46740749-46740750	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs3136431	chr11:46740871-46740872	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs372560648	chr11:46740874-46740875	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs145969693	chr11:46740907-46740908	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs113202549	chr11:46741020-46741021	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs142903294	chr11:46741059-46741060	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs370693897	chr11:46741069-46741070	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs566234614	chr11:46741091-46741092	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs374097100	chr11:46741160-46741161	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs35150107	chr11:46741178-46741179	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs533887406	chr11:46741187-46741188	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs371479474	chr11:46741221-46741222	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs547147827	chr11:46741232-46741233	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs570442167	chr11:46741234-46741235	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs376845267	chr11:46741238-46741239	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs144785536	chr11:46741275-46741276	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs148596790	chr11:46741280-46741281	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs368162633	chr11:46741345-46741346	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs374353447	chr11:46741352-46741353	Weak transcription Enhancers Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:157 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:46723600-46739800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr11:46725200-46739800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
3	chr11:46727600-46739800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
4	chr11:46728400-46739800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
5	chr11:46728800-46745600	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr11:46728800-46745600	Weak transcription	HUES64 Cell Line	embryonic stem cell
7	chr11:46729000-46739800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr11:46729200-46739800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr11:46729200-46740000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
10	chr11:46729400-46739800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
11	chr11:46729600-46739800	Weak transcription	HUES6 Cell Line	embryonic stem cell
12	chr11:46729600-46739800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
13	chr11:46729600-46739800	Weak transcription	Dnd41	blood
14	chr11:46729600-46740000	Weak transcription	Duodenum Mucosa	Duodenum
15	chr11:46729600-46740000	Weak transcription	Right Ventricle	heart
16	chr11:46729600-46740600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr11:46730000-46740000	Weak transcription	Gastric	stomach
18	chr11:46730200-46740600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr11:46730400-46739800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
20	chr11:46732800-46739800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr11:46733000-46739800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr11:46733000-46739800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
23	chr11:46733200-46739800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr11:46736600-46739800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr11:46736600-46740000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr11:46737000-46739800	Weak transcription	Muscle Satellite Cultured Cells	--
27	chr11:46737200-46739800	Weak transcription	Hela-S3	cervix
28	chr11:46738600-46739800	Enhancers	A549	lung
29	chr11:46739200-46740000	Enhancers	Liver	Liver
30	chr11:46739400-46740200	Enhancers	Sigmoid Colon	Sigmoid Colon
31	chr11:46739400-46740400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr11:46739400-46740400	Enhancers	Primary T cells fromperipheralblood	blood
33	chr11:46739400-46740400	Enhancers	Primary T helper cells fromperipheralblood	blood
34	chr11:46739400-46740400	Enhancers	Rectal Mucosa Donor 29	rectum
35	chr11:46739400-46741000	Enhancers	Fetal Intestine Large	intestine
36	chr11:46739400-46741000	Enhancers	Fetal Intestine Small	intestine
37	chr11:46739400-46741000	Enhancers	Stomach Mucosa	stomach
38	chr11:46739600-46739800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr11:46739600-46739800	Flanking Active TSS	HepG2	liver
40	chr11:46739600-46740000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr11:46739600-46740000	Enhancers	Adipose Nuclei	Adipose
42	chr11:46739600-46740000	Enhancers	HUVEC	blood vessel
43	chr11:46739600-46740200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
44	chr11:46739600-46740200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr11:46739600-46740200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr11:46739600-46740200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr11:46739600-46740200	Enhancers	Colonic Mucosa	Colon
48	chr11:46739600-46740200	Enhancers	Lung	lung
49	chr11:46739600-46740200	Enhancers	HSMM	muscle
50	chr11:46739600-46740200	Enhancers	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links